leisure time -WSS

leisure time

author：comprehensive 2025-09-03 03:26:33 - browse：742

Ron Wyden, left, and Mike Crapo, right. -- health policy coverage from STAT — Sens. Ron Wyden and Mike Crapo passed a new slate of pharmacy benefit manager reforms through the Finance Committee. Kevin Dietsch/Getty Images

WASHINGTON — A prominent Senate panel on Wednesday passed a new package of health policy reforms that would rein in certain pharmacy middlemen practices and ensure Medicare patients aren’t paying more than insurers do for medications.

The package passed the committee 26-0 with no amendments added. Sen. Ron Johnson (R-Wis.) didn’t vote.

The package, crafted by Senate Finance Chair Ron Wyden (D-Ore.) and Mike Crapo (R-Idaho) also includes policy on a broad range of health care priorities, including substance abuse and mental health care and extensions to provider pay. The pharmacy benefit manager regulations build on a separate package of PBM regulations that the panel passed in July.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： STAT Readout: Today's biotech news includes Sana and Amylyx

WSS

RaDonda Vaught to speak at CommonSpirit event on patient safety

Wellcome Trust names Røttingen as its new CEO

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

How doctors and nurses shape Google's AI

Pfizer highlights cancer drugs it thinks could reignite investor interest

European regulators consider appeal over Amylyx ALS drug

entertainment

leisure time

explore

The high cost of giving birth even with insurance

European regulators consider appeal over Amylyx ALS drug

Medical leaders decry Supreme Court decision on affirmative action

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Wildfire smoke exposes gaps in outdoor worker protections

Humana CEO Bruce Broussard to step down in 2024

Cancer drug shortages should be causing more outrage

Kenai launches with $82 million for Parkinson’s stem cell therapy

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

European regulators recommend Amylyx's ALS drug be rejected

leisure time

Eight reasons why you should get an updated Covid vaccine

Flu vaccine offering decent levels of protection this winter, new data show

AstraZeneca loses challenge to Medicare drug price negotiation

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Takeaways from AdvaMed, the largest medical devices conference

Readout LOUD podcast: Merger Mondays, Ozempic panic

Wikipedia

explore

hotspot

leisure time